Handbook of Psychiatric Drugs

Handbook of Psychiatric Drugs

Volumn , Issue , 2006, Pages 1-264

  Lieberman, Jeffrey A ^a,b   Tasman, Allan ^c  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63649145119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470029439     Document Type: Book

References (36)

1. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353(12):1209-1223
2. Miyamoto S, Duncan GE, Marx CE, Lieberman JA: Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular Psychiatry 2005; 10(1):79-104
3. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J; American Psychiatric Association; Steering Committee on Practice Guidelines: Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry 2004; 161(2 Suppl):1-56
4. Miyamoto S, Aoba A, Duncan GE, Lieberman JA: Acute Pharmacological Treatment of Schizophrenia. In: Schizophrenia, Second Edition. Blackwell Publishing, Oxford, 2002
5. Miyamoto S, Duncan GE, Goff DC, Lieberman JA: Therapeutics of Schizophrenia. In: Neuropsychopharmacology The Fifth Generation of Progress. Lippincott Williams & Wilkins, Philadelphia, pp. 775-807, 2002
6. Schooler NR, Kane JM: Research diagnosis for tardive dyskinesia. Arch. Gen. Psychiat. 1982; 39:486-487.
7. Weissman, MM. Treatment of Depression: Bridging the 21st Century. American Psychiatric Press, Washington D.C., 2001
8. Potokar J, Thase M. Advances in the Management and Treatment of Depression. Taylor & Francis, London, 2003
9. Lieberman JA, Greenhouse J, Hamer RM, Krishnan KR, Nemeroff CB, Sheehan DV, Thase ME, Keller MB: Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology 2005; 30(3):445-460.
10. Wong IC, Besag FM, Santosh PJ, Murray ML. Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Safety 2004; 27:991-1000.
11. Practice guidelines for the treatment of patients with major depressive disorder, Second Edition. In: American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders, Compendium 2004, American Psychiatric Publishing, Arlington VA, 2004.
12. Keck, PE, Jr., Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgrad Med Special Report. 2004(December): 1-120.
13. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 2004 Feb; 65(2):267-72.
14. Nutt DJ, Ballenger JC. Anxiety Disorders. Blackwell Publishing, Malden, MA, 2002
15. Pitman RK, Delahanty DL. Conceptually driven pharmacologic approaches to acute trauma. CNS Spectr. 2005; 10:99-106
16. McDonough M, Kennedy N. Pharmacological Management of Obsessive-Compulsive Disorder: A Review for Clinicians. Harvard Review of Psychiatry, May 2002; 10:127-137
17. Blanco C, Antia SX, Liebowitz MR. Pharmacotherapy of social anxiety disorder. Biological Psychiatry 2002; 51:109-120
18. Bandelow B, Ruther E. Treatment-resistant panic disorder. CNS Spectrums 2004; 9:725-739
19. Silber MH: Chronic insomnia. N Engl J Med 2005; 353:803-10
20. Roth T, Krystal A, Walsh J et al: Twelve months of nightly eszopiclone treatment in patients with chronic insomnia: assessment of long-term efficacy and safety. Sleep 2004; 27:A260
21. Buysee DJ, Reynolds CF, Kupfer DJ et al: Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994; 17:630-37
22. Morin CM, Colecchi C, Stone J et al: Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281:991-99
23. National Institutes of Health State of the Science Conference Statement: Manifestations and Management of Chronic Insomnia in Adults. June 13-15, 2005. Sleep 2005; 28(9)
24. Schatzberg AF and Nemeroff CB (Eds) (2004) The American Psychiatric Press Textbook of Psychopharmacology, 3rd edition, American Psychiatric Press, Washington, DC.
25. Greenhill LL, Shockey E, Halperin J, March J. (2003) Stimulants. In Psychiatry, 2nd edition (Eds Tasman A, Kay J, Lieberman JA), John Wiley & Sons, Ltd, London, 2062-2095.
26. MTA Cooperative Group (1999) 14 month randomized clinical trial of treatment strategies for children with attention deficit hyperactivity disorder. Archives of General Psychiatry 56 1073-1086.
27. MTA Cooperative Group (2004) National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 113(4) 754-761.
28. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold E, Beitchman J. (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry 41 26S-49S.
29. Greenhill L. (2002) Childhood attention deficit hyperactivity disorder: pharmacological treatments. In Treatments that Work, 2nd edition (Eds Nathan PE, Gorman J), Saunders, Philadelphia, 25-55.
30. Kaduszkiewicz H et al: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005; 331:321-327
31. Tasman A, Kay J, Lieberman JA (Eds): Psychiatry, 2nd edition, John Wiley & Sons, Ltd, London, 2003
32. Substance Abuse: A Comprehensive Textbook (4th Edition). Edited by Lowinson JH, Ruiz P, Millman RB, Langrod JG. Lippincott Williams and Wilkins, Philadelphia, 2005
33. Principles of Addiction Medicine (3rd Edition). Edited by Graham AW, Schultz TK, Mayo-Smith MF, Ries RD, Wilford BB. American Society of Addiction Medicine, Inc., Chevy Chase, Maryland, 2003
34. Textbook of Substance Abuse Treatment (3rd Edition). Edited by Galanter M, Kleber HD. American Psychiatric Publishing, Inc., Washington, D.C., 2004
35. Clinical Textbook of Addictive Disorders (3rd Edition). Edited by Frances RJ, Miller SI, Mack AH. The Guilford Press, New York, 2005
36. International Handbook of Alcohol Dependence and Problems. Edited by Heather N, Peters T, Stockwell T. John Wiley and Sons Ltd., Chichester, UK, 2001